5PSQ-026 Clinical importance of genetic variants in capecitabine bioactivation pathway for the prediction of response in colorectal cancer patients

Autor:	Y Cura, C Pérez-Ramírez, A Sánchez-Martín, MR Cantudo Cuenca, A Jimenez-Morales
Rok vydání:	2022
Zdroj:	Section 5: Patient safety and quality assurance.
DOI:	10.1136/ejhpharm-2022-eahp.263
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d41e89c3dd36149497fe8e8b42bca2f8 https://doi.org/10.1136/ejhpharm-2022-eahp.263 Zobrazit plný text záznamu